GB0005699D0 - Supplemented OMV vaccines - Google Patents

Supplemented OMV vaccines

Info

Publication number
GB0005699D0
GB0005699D0 GBGB0005699.4A GB0005699A GB0005699D0 GB 0005699 D0 GB0005699 D0 GB 0005699D0 GB 0005699 A GB0005699 A GB 0005699A GB 0005699 D0 GB0005699 D0 GB 0005699D0
Authority
GB
United Kingdom
Prior art keywords
supplemented
omv vaccines
omv
vaccines
supplemented omv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0005699.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Statens Institutt for Folkehelse
Original Assignee
Chiron SRL
Statens Institutt for Folkehelse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron SRL, Statens Institutt for Folkehelse filed Critical Chiron SRL
Priority to GBGB0005699.4A priority Critical patent/GB0005699D0/en
Publication of GB0005699D0 publication Critical patent/GB0005699D0/en
Priority to PCT/IB2001/000166 priority patent/WO2001052885A1/en
Priority to NZ520466A priority patent/NZ520466A/en
Priority to EP07013453.1A priority patent/EP1897555B1/en
Priority to EP10179761A priority patent/EP2281570A3/en
Priority to CA2871789A priority patent/CA2871789C/en
Priority to DE60142772T priority patent/DE60142772D1/en
Priority to US10/181,600 priority patent/US8273360B2/en
Priority to PT101785954T priority patent/PT2289545T/en
Priority to ES07013453.1T priority patent/ES2507100T3/en
Priority to DK01942562.8T priority patent/DK1248647T3/en
Priority to CN201110099744XA priority patent/CN102172398A/en
Priority to EP10178595.4A priority patent/EP2289545B1/en
Priority to PT70134531T priority patent/PT1897555E/en
Priority to PT01942562T priority patent/PT1248647E/en
Priority to EP10008222.1A priority patent/EP2275129A3/en
Priority to DK10178595.4T priority patent/DK2289545T3/en
Priority to CN018059201A priority patent/CN1416352B/en
Priority to JP2001552932A priority patent/JP2003520248A/en
Priority to BRPI0107679A priority patent/BRPI0107679B8/en
Priority to EP01942562A priority patent/EP1248647B1/en
Priority to CA2397508A priority patent/CA2397508C/en
Priority to ES01942562T priority patent/ES2348657T3/en
Priority to AT01942562T priority patent/ATE476988T1/en
Priority to BR0107679-5A priority patent/BR0107679A/en
Priority to MXPA02006962A priority patent/MXPA02006962A/en
Priority to DK07013453.1T priority patent/DK1897555T3/en
Priority to ES10178595.4T priority patent/ES2588917T3/en
Priority to AU28754/01A priority patent/AU784518B2/en
Priority to EP10179793A priority patent/EP2281571A3/en
Priority to RU2002122111/15A priority patent/RU2279889C2/en
Priority to AU2009200692A priority patent/AU2009200692B2/en
Priority to CY20101101003T priority patent/CY1111056T1/en
Priority to JP2011061748A priority patent/JP2011116793A/en
Priority to US13/591,138 priority patent/US20120328643A1/en
Priority to JP2013124556A priority patent/JP2013181037A/en
Priority to JP2013124554A priority patent/JP5823446B2/en
Priority to JP2013124555A priority patent/JP2013181036A/en
Priority to CY20141100751T priority patent/CY1115842T1/en
Priority to JP2015145631A priority patent/JP2015193652A/en
Priority to US14/882,320 priority patent/US20160030546A1/en
Priority to US14/961,725 priority patent/US20160082098A1/en
Priority to CY20161100845T priority patent/CY1117957T1/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0005699.4A 2000-01-17 2000-03-09 Supplemented OMV vaccines Ceased GB0005699D0 (en)

Priority Applications (43)

Application Number Priority Date Filing Date Title
GBGB0005699.4A GB0005699D0 (en) 2000-03-09 2000-03-09 Supplemented OMV vaccines
CA2397508A CA2397508C (en) 2000-01-17 2001-01-17 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
EP01942562A EP1248647B1 (en) 2000-01-17 2001-01-17 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
ES01942562T ES2348657T3 (en) 2000-01-17 2001-01-17 EXTERNAL MEMBRANE VESICULA (OMV) VACCINE THAT INCLUDES EXTERNAL MEMBRANE PROTEINS OF SEROGROUP B OF N. MENINGITIDIS.
EP07013453.1A EP1897555B1 (en) 2000-01-17 2001-01-17 Supplemented OMV vaccine against meningococcus
NZ520466A NZ520466A (en) 2000-01-17 2001-01-17 Outer membrane vesicle (OMV) vaccine comprising n. meningitidis serogroup B outer membrane proteins
CA2871789A CA2871789C (en) 2000-01-17 2001-01-17 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
DE60142772T DE60142772D1 (en) 2000-01-17 2001-01-17 MEMBRANE VEGETABLE (OMV) VACCINE CONTAINING N. MENINGITIDIS SEROGRUPPE B MEMBRANE PROTEINS
US10/181,600 US8273360B2 (en) 2000-01-17 2001-01-17 Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
PT101785954T PT2289545T (en) 2000-01-17 2001-01-17 Supplemented omv vaccine against meningococcus
ES07013453.1T ES2507100T3 (en) 2000-01-17 2001-01-17 OMV vaccine supplemented against meningococcus
DK01942562.8T DK1248647T3 (en) 2000-01-17 2001-01-17 Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
CN201110099744XA CN102172398A (en) 2000-01-17 2001-01-17 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
EP10178595.4A EP2289545B1 (en) 2000-01-17 2001-01-17 Supplemented OMV vaccine against meningococcus
PT70134531T PT1897555E (en) 2000-01-17 2001-01-17 Supplemented omv vaccine against meningococcus
PT01942562T PT1248647E (en) 2000-01-17 2001-01-17 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
EP10008222.1A EP2275129A3 (en) 2000-01-17 2001-01-17 Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
AT01942562T ATE476988T1 (en) 2000-01-17 2001-01-17 MEMBRANE VESICLE (OMV) VACCINE CONTAINING N. MENINGITIDIS SEROGROUP B MEMBRANE PROTEINS
CN018059201A CN1416352B (en) 2000-01-17 2001-01-17 Outer membrane vesicle (OMV) vaccine comprising N. Meningitidis serogroup B outer membrane
JP2001552932A JP2003520248A (en) 2000-01-17 2001-01-17 N. Outer Membrane Vesicle (OMV) Vaccine Comprising MENINGITIDIS Serotype B Outer Membrane Protein
BRPI0107679A BRPI0107679B8 (en) 2000-01-17 2001-01-17 composition comprising Neisseria meningitidis serum group b outer membrane vesicles and an inorganic component and use thereof
PCT/IB2001/000166 WO2001052885A1 (en) 2000-01-17 2001-01-17 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
RU2002122111/15A RU2279889C2 (en) 2000-01-17 2001-01-17 OUTER MEMBRANE VESICLE VACCINE (OMV) CONTAINING PROTEINS OF SEROGROUP B N.Meningitis OUTER MEMBRANE
EP10179761A EP2281570A3 (en) 2000-01-17 2001-01-17 Outer membrane vesicle (OMV) vaccine comprising n. meningitidis serogroup B outer membrane proteins
DK10178595.4T DK2289545T3 (en) 2000-01-17 2001-01-17 Supplemented OMV vaccine against meningococcus
BR0107679-5A BR0107679A (en) 2000-01-17 2001-01-17 Outer membrane vesicle (omv) vaccine comprising neisseria meningitidis serum group b outer membrane proteins
MXPA02006962A MXPA02006962A (en) 2000-01-17 2001-01-17 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins.
DK07013453.1T DK1897555T3 (en) 2000-01-17 2001-01-17 Supplemental OMV vaccine against meningococcus
ES10178595.4T ES2588917T3 (en) 2000-01-17 2001-01-17 VME supplement supplemented against meningococcus
AU28754/01A AU784518B2 (en) 2000-01-17 2001-01-17 Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
EP10179793A EP2281571A3 (en) 2000-01-17 2001-01-17 Outer membrane vesicle (omv) vaccine comprising n. meningitidids serogroup b outer membrane proteins
AU2009200692A AU2009200692B2 (en) 2000-01-17 2009-02-19 Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
CY20101101003T CY1111056T1 (en) 2000-01-17 2010-11-04 Outer Membrane Vaccine Vaccine (OMV) INCLUDING Outer Membrane Proteins BY N. MENINGITIDIS SERIAL B
JP2011061748A JP2011116793A (en) 2000-01-17 2011-03-18 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane protein
US13/591,138 US20120328643A1 (en) 2000-01-17 2012-08-21 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
JP2013124555A JP2013181036A (en) 2000-01-17 2013-06-13 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane protein
JP2013124554A JP5823446B2 (en) 2000-01-17 2013-06-13 N. Outer membrane vesicle (OMV) vaccine containing MENINGITIDIS serotype B outer membrane protein
JP2013124556A JP2013181037A (en) 2000-01-17 2013-06-13 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane protein
CY20141100751T CY1115842T1 (en) 2000-01-17 2014-09-17 SUBMITTED OMV VACCINE AGAINST MINING
JP2015145631A JP2015193652A (en) 2000-01-17 2015-07-23 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
US14/882,320 US20160030546A1 (en) 2000-01-17 2015-10-13 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
US14/961,725 US20160082098A1 (en) 2000-01-17 2015-12-07 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
CY20161100845T CY1117957T1 (en) 2000-01-17 2016-08-29 FULL OMV VACANCY AGAINST MININGOKOK

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0005699.4A GB0005699D0 (en) 2000-03-09 2000-03-09 Supplemented OMV vaccines

Publications (1)

Publication Number Publication Date
GB0005699D0 true GB0005699D0 (en) 2000-05-03

Family

ID=9887293

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0005699.4A Ceased GB0005699D0 (en) 2000-01-17 2000-03-09 Supplemented OMV vaccines

Country Status (2)

Country Link
ES (1) ES2348657T3 (en)
GB (1) GB0005699D0 (en)

Also Published As

Publication number Publication date
ES2348657T3 (en) 2010-12-10

Similar Documents

Publication Publication Date Title
GB0020953D0 (en) Vaccine
HUP0301092A3 (en) Vaccine
IL155072A0 (en) Vaccine
IL155282A0 (en) Vaccines
GB0130215D0 (en) Vaccine
HUP0402259A3 (en) Vaccines
GB0407935D0 (en) Vaccine
AU1591402A (en) Vaccine
HUP0303372A3 (en) Vaccine
EP1423141A4 (en) Vaccine
GB0121171D0 (en) Vaccine
GB0014288D0 (en) Vaccine
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
GB0025694D0 (en) Vaccine
GB0105238D0 (en) Vaccines
GB0003082D0 (en) Vaccine
GB0005699D0 (en) Supplemented OMV vaccines
GB0004533D0 (en) Vaccines
GB0006693D0 (en) Vaccine
GB0015722D0 (en) Vaccine
GB0015935D0 (en) Vaccine
GB0006281D0 (en) Vaccines
GB0014280D0 (en) Vaccines
GB0025575D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)